發送短信 : Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

  _____    __   __   __   _    _    _    ______   
 / ____||  \ \\/ // | || | || | || | || |      \\ 
/ //---`'   \ ` //  | '--' || | || | || |  --  // 
\ \\___      | ||   | .--. || | \\_/ || |  --  \\ 
 \_____||    |_||   |_|| |_||  \____//  |______// 
  `----`     `-`'   `-`  `-`    `---`   `------`